Last updated 2026-07-23
- Raised $25M funding round led by Temasek, Sep 2017
- Raised $75M Undisclosed Round
Total raised
$100.0M
Last: Undisclosed Round
Stage
Mature
Founded
2012
Headcount
31
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
Website ↗Registrar ID: 514782622 (AYANA PHARMA LTD)
About
Ayana Pharma (formerly DoxoCure) is an Israeli pharmaceutical company focused on the development and manufacturing of liposomal therapeutics for the treatment of cancer and other diseases. The company was founded in 2012 to leverage the benefits of Doxil, an FDA-approved liposomal nanodrug. Ayana Pharma is developing a generic version of Doxil (LC-101) and other liposomal pharmaceutical products, aiming to expand their uses and efficacy while making them more readily available. The company has completed fundraising to support its Abbreviated New Drug Application (ANDA) filing and commercialization.
Funding history · 2 rounds · $100.0M total
2 events/rounds · $100.0M Total Funding: $100.0M in Private Equity
Sep 2017
$25.0M
globes.co.il
Date unknown
Undisclosed Round
$75.0M
quoted-total
Offices
Jerusalem, Israel · HQ / main office
Q&A
- What is Ayana Pharma's primary focus?
- Ayana Pharma specializes in developing liposome-based treatments for cancer, leveraging the technology of the FDA-approved drug Doxil.
- When was Ayana Pharma founded?
- Ayana Pharma was founded in June 2012.
- Who co-founded Ayana Pharma?
- Ayana Pharma was co-founded by Professor Yechezkel Barenholz, one of the co-inventors of Doxil from the Hebrew University.
- What is Ayana Pharma's employee count?
- Ayana Pharma has an employee count in the 11-50 range.
- What is Ayana Pharma's current product stage?
- Ayana Pharma's product is currently in the released stage.
- What is Ayana Pharma's primary sector?
- Ayana Pharma's primary sector is Health Tech & Life Sciences.
- Which investors have participated in Ayana Pharma's funding rounds?
- Investors in Ayana Pharma's funding rounds include Integra Holdings.
- What is Ayana Pharma's current stage according to startupim data?
- Ayana Pharma is currently classified as a Mature company.
Team · 5
Prof. Yechezkel Barenholz
Founder · Co-Founder & CEO
Avi Molcho
Founder · Co-founder (No longer with the company)
Gal Cohen
Executive Chairman
Yanir Aldouby
COO
Dima Shamrakov
VP R&D
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersPatients
Business model
B2B
Tags
cancergeneric-drugsmedical-technologiesdrug-deliveryspace-techpharmaceuticalshospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ayanapharma.com/ |
|---|
Identifiers & details
| Legal name | AYANA PHARMA LTD |
|---|---|
| Former names | DoxoCure |
| Founded | 2012-6 |
| Employees (exact) | 31 |
Acquisitions & public offerings
Acquired by 2025-10 $7.0M
Radar intelligence
Web history (Wayback)
| Domain | ayanapharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514782622 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-06-12 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — people (2), shares_capital (2) |
| Registered address | עין כרם 0 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-24 | עדכון דירקטורים-הוספת דירקטור |
| 2025-08-14 | הקצאת מניות |
| 2025-09-11 | עדכון דירקטורים-הסרת דירקטור |
| 2025-09-07 | העברת מניות |